HCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-κB

Viral Immunology

Volumn 21, Issue 4, 2008, Pages 477-482

  Nachtwey, James ^a   Spencer, Juliet V ^a  

^a UNIVERSITY OF SAN FRANCISCO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HUMAN INTERLEUKIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; ENZYME DEGRADATION; ENZYME INHIBITION; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MONOCYTE; PERSISTENT VIRUS INFECTION; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION;

CELL LINE; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DOWN-REGULATION; GENE EXPRESSION; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-10; MONOCYTES; NF-KAPPA B; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 58149232443     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2008.0048     Document Type: Article

References (42)

1. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, and Schaffner W: A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985;41:521-530.
2. Britt WJ and CA Alford: Cytomegalovirus. In: Fields Virology, 3rd ed. (Fields DMKBN, Howley PM, et al., eds.). Lippincott-Raven, Philadelphia, 1996, pp. 2493-2523.
3. Brooks DG, Lee AM, Elsaesser H, McGavern DB, and Oldstone MB: IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med 2008;205:533-541.
4. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, and Oldstone MB: Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006;12:1301-1309.
5. Cao S, Zhang X, Edwards JP, and Mosser DM: NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 2006;281:26041-26050.
6. Chang W, Baumgarth N, Greg JP, Baron CA, and Barry PA: HCMV-encoded IL-10 alters dendritic cell functionality: a comprehensive comparison with cellular IL-10. 29th International Herpesvirus Workshop, Reno, NV, 2004.
7. Chang WL, Baumgarth N, Yu D, and Barry PA: Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol 2004;78:8720-8731.
8. Collart MA, Baeuerle P, and Vassalli P: Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 1990;10:1498-1506.
9. de la Hoz RE, Stephens G, and Sherlock C: Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol 2002;25(Suppl 2):S1-12.
10. DeMeritt IB, Milford LE, and Yurochko AD: Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol 2004;78:4498-4507.
11. DeMeritt IB, Podduturi JP, Tilley AM, Nogalski MT, and Yurochko AD: Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression. Virology 2006;346:15-31.
12. Driessler F, Venstrom K, Sabat R, Asadullah K, and Schottelius AJ: Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol 2004;135:64-73.
13. El Kasmi KC, Holst J, Coffre M, et al.: General nature of the STAT3-activated anti-inflammatory response. J Immunol 2006;177:7880-7888.
14. Emery VC: Cytomegalovirus and the aging population. Drugs Aging 2001;18:927-933.
15. Geist LJ: The self defense of cytomegalovirus: in this case the lawyer is no fool. Transplantation 2008;86:202-203.
16. Hiscott J, Marois J, Garoufalis J, et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 1993;13:6231-6240.
17. Isomura H, and Stinski MF: The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection. J Virol 2003;77:3602-3614.
18. Jones BC, Logsdon NJ, Josephson K, Cook J, Barry PA, and Walter MR: Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc Natl Acad Sci USA 2002;99:9404-9409.
19. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, and Pestka S: Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 2000;97:1695-1700.
20. Kuwata H, Watanabe Y, Miyoshi H, Yamamoto M, Kaisho T, Takeda K, and Akira S: IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 2003;102:4123-4129.
21. Lee SH, and Hannink M: The N-terminal nuclear export sequence of IkappaBalpha is required for RanGTP-dependent binding to CRM1. J Biol Chem 2001;276:23599-23606.
22. Li Q, and Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2:725-734.
23. May MJ, and Ghosh S: Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol 1997;8:63-73.
24. Meier JL, and Pruessner JA: The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression. J Virol 2000;74:1602-1613.
25. Mocarski ES: Cytomegaloviruses and their replication. In: Fields Virology, 3rd ed. (Fields DMKBN, Howley PM, et al., eds.). Lippincott-Raven Publishers, Philadelphia, 1996, pp. 2447-2492.
26. Murray PJ: The JAK-STAT signaling pathway: input and output integration. J Immunol 2007;178:2623-2629.
27. Niemand C, Nimmesgern A, Haan S, et al.: Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003;170:3263-3672.
28. Qin H, Roberts KL, Niyongere SA, Cong Y, Elson CO, and Benveniste EN: Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. J Immunol 2007;179:5966-5976.
29. Qin H, Wilson CA, Roberts KL, Baker BJ, Zhao X, and Benveniste EN: IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J Immunol 2006;177: 7761-7771.
30. Raftery MJ, Wieland D, Gronewald S, Kraus AA, Giese T, and Schonrich G: Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J Immunol 2004;173:3383-3391.
31. Riley JK, Takeda K, Akira S, and Schreiber RD: Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 1999;274:16513-16521.
32. Rivera LB, Boppana SB, Fowler KB, Britt WJ, Stagno S, and Pass RF: Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics 2002;110:762-767.
33. Sambucetti LC, Cherrington JM, Wilkinson GW, and Mocarski ES: NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J 1989;8:4251-4258.
34. Schottelius AJ, Mayo MW, Sartor RB, and Baldwin AS Jr: Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 1999;274:31868-31874.
35. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, and Jongeneel CV: Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 1990;171:35-47.
36. Siebenlist U, Brown K, and Claudio E: Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 2005;5:435-445.
37. Spencer JV: The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes. J Virol 2007;81:2083-2086.
38. Spencer JV, Cadaoas J, Castillo PR, Saini V, and Slobedman B: Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology 2008;374:164-169.
39. Spencer JV, Lockridge KM, Barry PA, Lin G, Tsang M, Penfold ME, and Schall TJ: Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 2002;76:1285-1292.
40. Tabary O, Muselet C, Escotte S, Antonicelli F, Hubert D, Dusser D, and Jacquot J: Interleukin-10 inhibits elevated chemokine interleukin-8 and regulated on activation normal T cell expressed and secreted production in cystic fibrosis bronchial epithelial cells by targeting the I(k)B kinase alpha/beta complex. Am J Pathol 2003;162:293-302.
41. Tam WF, Lee LH, Davis L, and Sen R: Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export. Mol Cell Biol 2000;20:2269-2284.
42. Thomsen DR, Stenberg RM, Goins WF, and Stinski MF: Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc Natl Acad Sci USA 1984;81:659-663.